This is the text extract for August Tender Results, browse documents here.

---

31 August 2009

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept and decline tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 11th September 2009. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2007/08 Tender Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 21 December 2007.

The decisions were as follows:

Chemical Name Domperidone Vancomycin hydrochloride

Line Item Tab 10 mg Cap 250 mg

2008/09 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to listed pharmaceuticals where no other brand is listed – subsidy changes (where applicable) on 1 October 2009 and Sole Subsidised Supply commences on 1 January 2010.

The decisions were as follows:

Chemical Name Atropine sulphate Baclofen Betamethasone valerate Clobetasol propionate

Presentation; Pack size and type Inj 600 mcg, 1 ml; 50 injections, ampoule Tab 10 mg; 100 tablets, bottle Scalp app 0.1%; 100 ml OP, bottle Crm 0.05%; 30 g OP, bottle

Current Subsidy $26.00 $3.75 $5.25 $2.35

New tender subsidy $52.00 $4.75 $7.22 $3.48

Sole supply brand (Supplier) AstraZeneca (AstraZeneca) Pacifen (Mylan) Beta Scalp (Mylan) Dermol (Mylan)

A298088 - qA12214

---

Chemical Name Clobetasol propionate Clobetasol propionate Clonidine hydrochloride Clonidine hydrochloride Clonidine hydrochloride Clonidine Clonidine Clonidine Flucloxacillin sodium Flucloxacillin sodium

Presentation; Pack size and type Oint 0.05%; 30 g OP, bottle Scalp app 0.05%; 30 ml OP, bottle Inj 150 mcg per ml, 1 ml; 5 injections, ampoule Tab 25 mcg; 100 tablets, blister Tab 150 mcg; 100 tablets, blister TDDS 2.5 mg, 100 mcg per day; 4 patches, sachet TDDS 5 mg, 200 mcg per day; 4 patches, sachet TDDS 7.5 mg, 300 mcg per day; 4 patches, sachet Grans for oral liq 125 mg per 5 ml; 100 ml, bottle Grans for oral liq 250 mg per 5 ml; 100 ml, bottle Tab 5 mg; 100 tablets, bottle Tab 20 mg; 100 tablets, bottle

Current Subsidy $1.60 $3.20 $14.00 $17.53 $30.33 $21.29 $30.79 $39.10 $2.05 $2.72 $4.56 $7.95 $19.95 $21.10 $151.40 $412.59 $16.45 $42.57 $49.45 $26.11 $8.06 $8.56 $9.61 $12.56 $2.64 $5.10 $21.00 $17.95 $5.40 $6.80 $9.20 $5.20

New tender subsidy $3.48 $6.36 $15.45 $19.25 $33.00 $23.30 $32.80 $41.20 $3.12 $3.55 $9.00 $8.35 $20.95 $23.00 $151.40 $412.59 $20.80 $42.57 $69.23 $31.33 $8.84 $11.62 $14.65 $21.55 $2.80 $5.52 $23.70 $24.88 $5.94 $7.48 $10.12 $7.00

Sole supply brand (Supplier) Dermol (Mylan) Dermol (Mylan) Catapres (Boehringer Ingelheim) Dixarit (Boehringer Ingelheim) Catapres (Boehringer Ingelheim) Catapres-TTS-1 (Boehringer Ingelheim) Catapres-TTS-2 (Boehringer Ingelheim) Catapres-TTS-3 (Boehringer Ingelheim) AFT (AFT) AFT (AFT) Pfizer (Pfizer) Douglas (Douglas) Douglas (Douglas) Colifoam (Aspen Pharmacare) Solu-Medrol (Pfizer) Solu-Medrol (Pfizer) Solu-Medrol (Pfizer) Solu-Medrol (Pfizer) Apo-Moclobemide (Apotex) Apo-Moclobemide (Apotex) RA-Morph (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) Sevredol (Douglas) Sevredol (Douglas) Noflam 250 (Mylan) Noflam 500 (Mylan) Syntocinon (Novartis) Syntocinon (Novartis) Syntometrine (Novartis) Span-K (Aspen Pharmacare)

Gentamicin sulphate Inj 40 mg per ml, 2 ml; 10 injections, ampoule Hydrocortisone Hydrocortisone

Hydrocortisone Rectal foam 10%, CFC-free (14 applications); acetate 21.1 g OP, aerosol Methylprednisolone Inj 40 mg per ml, 1 ml; 25 injections, vial sodium succinate Methylprednisolone Inj 62.5 mg per ml, 2 ml; 25 injections, vial sodium succinate Methylprednisolone Inj 500 mg; 1 injection, vial sodium succinate Methylprednisolone Inj 1 g; 1 injection, vial sodium succinate Moclobemide Moclobemide Morphine hydrochloride Morphine hydrochloride Morphine hydrochloride Morphine hydrochloride Morphine sulphate Morphine sulphate Naproxen Naproxen Oxytocin Oxytocin Oxytocin Potassium chloride Tab 150 mg; 500 tablets, bottle Tab 300 mg; 100 tablets, bottle Oral liq 1 mg per ml; 200 ml, bottle Oral liq 2 mg per ml; 200 ml, bottle Oral liq 5 mg per ml; 200 ml, bottle Oral liq 10 mg per ml; 200 ml, bottle Tab immediate release 10 mg; 10 tablets, blister Tab immediate release 20 mg; 10 tablets, blister Tab 250 mg; 500 tablets, bottle Tab 500 mg; 250 tablets, bottle Inj 5 iu per ml, 1 ml; 5 injections, ampoule Inj 10 iu per ml, 1 ml; 5 injections, ampoule Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml; 5 injections, ampoule Tab long-acting 600 mg; 200 tablets, bottle

A298088 - qA12214

Page 2 of 5

---

Chemical Name Quinine sulphate Sodium cromoglycate

Presentation; Pack size and type Tab 300 mg; 500 tablets, bottle Nasal spray, 4%; 22 ml OP, bottle

Current Subsidy $34.75 $13.50

New tender subsidy $54.06 $15.85

Sole supply brand (Supplier) Q 300 (Mylan) Rex (Rex Medical)

2. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 October 2009, reference pricing of nontender winning brand will occur on 1 December 2009 and Sole Subsidised Supply commences on 1 March 2010.

The decisions were as follows:

Chemical Name Latanoprost

Presentation; Pack size and type Eye drops 50 mcg per ml; 2.5 ml OP, bottle

Current subsidy $19.50

New tender subsidy $9.75

Sole supply brand (Supplier) Hysite (Pfizer)

Brands affected by reference pricing and delisting Xalatan (Pfizer)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 3. Tenders awarded to listed pharmaceuticals where only the current brand is listed – price changes (where applicable) for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 October 2009; DV Limits and DV Pharmaceuticals will apply from 1 December 2009.

The decisions were as follows:

Chemical Name Atropine sulphate Baclofen Betamethasone valerate Carboplatin+ Carboplatin+ Carboplatin+ Carboplatin+ Clobetasol propionate Clonidine hydrochloride

Presentation; Pack size and type Inj 600 mcg, 1 ml; 50 injections, ampoule Tab 10 mg; 100 tablets, bottle Scalp app 0.1%; 100 ml, bottle Inj 10 mg per ml, 5 ml; 1 injection, vial Inj 10 mg per ml, 15 ml; 1 injection, vial Inj 10 mg per ml, 45 ml; 1 injection, vial Inj 10 mg per ml, 100 ml; 1 injection, vial Crm 0.05%; 30 g, bottle

Hospital Supply Brand (Supplier) AstraZeneca (AstraZeneca) Pacifen (Mylan) Beta Scalp (Mylan) Carboplatin Ebewe (InterPharma) Carboplatin Ebewe (InterPharma) Carboplatin Ebewe (InterPharma) Carboplatin Ebewe (InterPharma) Dermol (Mylan)

Pack Price $52.00 $4.75 $7.22 $20.00 $22.50 $55.00 $120.00 $3.48 $15.45 $33.00 $23.30

DV Limit 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) Alpha-Baclofen (Apotex) (B) Hospira (Hospira) Pfizer (Pfizer) Hospira (Hospira) Pfizer (Pfizer) Hospira (Hospira) Pfizer (Pfizer) Hospira (Hospira) Pfizer (Pfizer) (B) (B) (B) (B)

Inj 150 mcg per ml, 1 ml; 5 injections, Catapres (Boehringer ampoule Ingelheim) Catapres (Boehringer Clonidine hydrochloride Tab 150 mcg; 100 tablets, blister Ingelheim) Catapres-TTS-1 TDDS 2.5 mg, 100 mcg per day; 4 Clonidine (Boehringer patches, sachet Ingelheim) Catapres-TTS-2 TDDS 5 mg, 200 mcg per day; 4 Clonidine (Boehringer patches, sachet Ingelheim) Clonidine Flucloxacillin sodium TDDS 7.5 mg, 300 mcg per day; 4 patches, sachet Grans for oral liq 125 mg per 5 ml; 100 ml, bottle Catapres-TTS-3 (Boehringer Ingelheim) AFT (AFT)

$32.80

1%

(B)

$41.20 $3.12

1% 1%

(B) (B)

A298088 - qA12214

Page 3 of 5

---

Chemical Name Flucloxacillin sodium Gentamicin sulphate Glyceryl trinitrate Glyceryl trinitrate Hydrocortisone Hydrocortisone Hydrocortisone acetate Hydroxyethyl starch 200/0.5* Methylprednisolone sodium succinate Methylprednisolone sodium succinate Methylprednisolone sodium succinate Methylprednisolone sodium succinate Morphine hydrochloride Morphine hydrochloride Morphine hydrochloride Morphine hydrochloride Morphine sulphate Morphine sulphate Oxytocin Oxytocin

Presentation; Pack size and type Grans for oral liq 250 mg per 5 ml; 100 ml, bottle Inj 40 mg per ml, 2 ml; 10 injections, ampoule Inj 1 mg per ml, 5 ml; 10 injections, ampoule Inj 1 mg per ml, 50 ml; 10 injections, ampoule Tab 5 mg; 100 tablets, bottle Tab 20 mg; 100 tablets, bottle Rectal foam 10%, CFC-free (14 applications); 21.1 g, aerosol Inj 6%; 16 injections, bag

Hospital Supply Brand (Supplier) AFT (AFT) Pfizer (Pfizer) Nitronal (Douglas) Nitronal (Douglas) Douglas (Douglas) Douglas (Douglas) Colifoam (Aspen Pharmacare) StarQuin 200 6% (Biomed)

Pack Price $3.55 $9.00 $22.70 $86.60 $8.35 $20.95 $23.00 $296.00 $151.40 $412.59 $20.80 $42.57 $8.84 $11.62 $14.65 $21.55 $2.80 $5.52 $5.94

DV Limit 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) Hospira (Hospira) (B) (B) (B) (B) (B) HAES-steril 6% (Pharmatel Fresenius Kabi) (B) (B) Hospira (Hospira) Hospira (Hospira) (B) (B) (B) (B) (B) (B) (B) (B) (B) (B) Slow-K (Novartis) K-SR (Mylan) Apo-Quinine (Apotex)

Inj 40 mg per ml, 1 ml; 25 injections, Solu-Medrol (Pfizer) vial Inj 62.5 mg per ml, 2 ml; 25 injections, Solu-Medrol (Pfizer) vial Inj 500 mg; 1 injection, vial Inj 1 g; 1 injection, vial Oral liq 1 mg per ml; 200 ml, bottle Oral liq 2 mg per ml; 200 ml, bottle Oral liq 5 mg per ml; 200 ml, bottle Oral liq 10 mg per ml; 200 ml, bottle Tab immediate release 10 mg; 10 tablets, blister Tab immediate release 20 mg; 10 tablets, blister Inj 5 iu per ml, 1 ml; 5 injections, ampoule Solu-Medrol (Pfizer) Solu-Medrol (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) Sevredol (Douglas) Sevredol (Douglas) Syntocinon (Novartis)

Inj 10 iu per ml, 1 ml; 5 injections, Syntocinon (Novartis) $7.48 ampoule Inj 5 iu with ergometrine maleate 500 Syntometrine Oxytocin $10.12 mcg per ml, 1 ml; 5 injections, ampoule (Novartis) Inj 2 mg per ml, 2 ml; 50 injections, AstraZeneca Pancuronium bromide $128.00 ampoule (AstraZeneca) Potassium chloride Quinine sulphate Tab long-acting 600 mg; 200 tablets, bottle Tab 300 mg; 500 tablets, bottle Span-K (Aspen Pharmacare) Q 300 (Mylan) $7.00 $54.06

*Hydroxyethyl starch 200/0.5 was previously described as pentastarch in Part II of Section H. + Please note the pricing of Carboplatin Ebewe in Section B of the Pharmaceutical Schedule for PCT and ECP preparations will be amended accordingly.

4. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 October 2009 and DV Limits and DV Pharmaceuticals will apply from 1 December 2009.

The decisions were as follows:

A298088 - qA12214

Page 4 of 5

---

Chemical Name Naproxen Naproxen Clobetasol propionate Clobetasol propionate Clonidine hydrochloride Moclobemide Moclobemide

Presentation; Pack size and type Tab 250 mg; 500 tablets, bottle Tab 500 mg; 250 tablets, bottle Oint 0.05%; 30 g, bottle Scalp app 0.05%; 30 ml, bottle Tab 25 mcg; 100 tablets, blister Tab 150 mg; 500 tablets, bottle Tab 300 mg; 100 tablets, bottle

Hospital Supply Brand (Supplier) Noflam 250 (Mylan) Noflam 500 (Mylan) Dermol (Mylan) Dermol (Mylan) Dixarit (Boehringer Ingelheim) Apo-Moclobemide (Apotex) Apo-Moclobemide (Apotex)

Pack Price $23.70 $24.88 $3.48 $6.36 $19.25 $69.23 $31.33

DV Limit 1% 1% 1% 1% 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) Naxen (Douglas) Naxen (Douglas) (B) Clobex Shampoo (HCL) (B) (B) (B)

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 23 December 2008.

The decisions were as follows:

Chemical Name Beclomethasone dipropionate Beclomethasone dipropionate Isotretinoin Morphine sulphate Morphine sulphate Morphine sulphate Morphine sulphate Morphine sulphate Lorazepam Lorazepam

Line Item Metered aqueous nasal spray, 50 mcg per dose Metered aqueous nasal spray, 100 mcg per dose Cap 40 mg Cap long-acting 10 mg Cap long-acting 30 mg Cap long-acting 60 mg Cap long-acting 100 mg Cap long-acting 200 mg Tab 1 mg Tab 2.5 mg

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A298088 - qA12214

Page 5 of 5